Skip to main content

Glucose-regulated protein 94/glycoprotein 96 elicits bystander activation of CD4+ T cell Th1 cytokine production in vivo.

Publication ,  Journal Article
Baker-LePain, JC; Sarzotti, M; Nicchitta, CV
Published in: J Immunol
April 1, 2004

Glucose-regulated protein 94 (GRP94/gp96), the endoplasmic reticulum heat shock protein 90 paralog, elicits both innate and adaptive immune responses. Regarding the former, GRP94/gp96 stimulates APC cytokine expression and dendritic cell maturation. The adaptive component of GRP94/gp96 function reflects a proposed peptide-binding activity and, consequently, a role for native GRP94/gp96-peptide complexes in cross-presentation. It is by this mechanism that tumor-derived GRP94/gp96 is thought to suppress tumor growth and metastasis. Recent data have demonstrated that GRP94/gp96-elicited innate immune responses can be sufficient to suppress tumor growth and metastasis. However, the immunological processes activated in response to tumor Ag-negative sources of GRP94/gp96 are currently unknown. We have examined the in vivo immunological response to nontumor sources of GRP94/gp96 and report that administration of syngeneic GRP94/gp96- or GRP94/gp96-N-terminal domain-secreting KBALB fibroblasts to BALB/c mice stimulates CD11b(+) and CD11c(+) APC function and promotes bystander activation of CD4(+) T cell Th1 cytokine production. Only modest activation of CD8(+) T cell or NK cell cytolytic function was observed. The GRP94/gp96-dependent induction of CD4(+) T cell cytokine production was markedly inhibited by carrageenan, indicating an essential role for APC in this response. These results identify the bystander activation of CD4(+) T lymphocytes as a previously unappreciated immunological consequence of GRP94/gp96 administration and demonstrate that GRP94/gp96-elicited alterations in the in vivo cytokine environment influence the development of CD4(+) T cell effector functions, independently of its proposed function as a peptide chaperone.

Duke Scholars

Published In

J Immunol

DOI

ISSN

0022-1767

Publication Date

April 1, 2004

Volume

172

Issue

7

Start / End Page

4195 / 4203

Location

England

Related Subject Headings

  • Tumor Necrosis Factor-alpha
  • Th1 Cells
  • T-Lymphocyte Subsets
  • Phagocytes
  • Mice, Inbred BALB C
  • Mice
  • Membrane Proteins
  • Lymphoid Tissue
  • Lymphocyte Activation
  • Killer Cells, Natural
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Baker-LePain, J. C., Sarzotti, M., & Nicchitta, C. V. (2004). Glucose-regulated protein 94/glycoprotein 96 elicits bystander activation of CD4+ T cell Th1 cytokine production in vivo. J Immunol, 172(7), 4195–4203. https://doi.org/10.4049/jimmunol.172.7.4195
Baker-LePain, Julie C., Marcella Sarzotti, and Christopher V. Nicchitta. “Glucose-regulated protein 94/glycoprotein 96 elicits bystander activation of CD4+ T cell Th1 cytokine production in vivo.J Immunol 172, no. 7 (April 1, 2004): 4195–4203. https://doi.org/10.4049/jimmunol.172.7.4195.
Baker-LePain JC, Sarzotti M, Nicchitta CV. Glucose-regulated protein 94/glycoprotein 96 elicits bystander activation of CD4+ T cell Th1 cytokine production in vivo. J Immunol. 2004 Apr 1;172(7):4195–203.
Baker-LePain, Julie C., et al. “Glucose-regulated protein 94/glycoprotein 96 elicits bystander activation of CD4+ T cell Th1 cytokine production in vivo.J Immunol, vol. 172, no. 7, Apr. 2004, pp. 4195–203. Pubmed, doi:10.4049/jimmunol.172.7.4195.
Baker-LePain JC, Sarzotti M, Nicchitta CV. Glucose-regulated protein 94/glycoprotein 96 elicits bystander activation of CD4+ T cell Th1 cytokine production in vivo. J Immunol. 2004 Apr 1;172(7):4195–4203.

Published In

J Immunol

DOI

ISSN

0022-1767

Publication Date

April 1, 2004

Volume

172

Issue

7

Start / End Page

4195 / 4203

Location

England

Related Subject Headings

  • Tumor Necrosis Factor-alpha
  • Th1 Cells
  • T-Lymphocyte Subsets
  • Phagocytes
  • Mice, Inbred BALB C
  • Mice
  • Membrane Proteins
  • Lymphoid Tissue
  • Lymphocyte Activation
  • Killer Cells, Natural